has been cited by the following article(s):
[1]
|
The role of the prolactin receptor pathway in the pathogenesis of glioblastoma: what do we know so far?
Expert Opinion on Therapeutic Targets,
2020
DOI:10.1080/14728222.2020.1821187
|
|
|
[2]
|
Prolactin and its receptor as therapeutic targets in glioblastoma multiforme
Scientific Reports,
2019
DOI:10.1038/s41598-019-55860-x
|
|
|
[3]
|
Prolactin and its receptor as therapeutic targets in glioblastoma multiforme
Scientific Reports,
2019
DOI:10.1038/s41598-019-55860-x
|
|
|
[4]
|
Prolactin and its receptor as therapeutic targets in glioblastoma multiforme
Scientific Reports,
2019
DOI:10.1038/s41598-019-55860-x
|
|
|
[5]
|
Unique features of pregnancy-related meningiomas: lessons learned from 148 reported cases and theoretical implications of a prolactin modulated pathogenesis
Neurosurgical Review,
2016
DOI:10.1007/s10143-016-0762-3
|
|
|
[6]
|
Prolactin gene expression in primary central nervous system tumors
Journal of Negative Results in BioMedicine,
2013
DOI:10.1186/1477-5751-12-4
|
|
|